Resuscitation Strategies for Traumatic Brain Injury

  • Henry W. Caplan
  • Charles S. CoxJr.Email author
Traumatic Brain Injury Surgery (S. Timmons, Section Editor)
Part of the following topical collections:
  1. Traumatic Brain Injury Surgery


Purpose of Review

Traumatic brain injury (TBI) is a leading cause of morbidity and mortality; however, little definitive evidence exists about most clinical management strategies. Here, we highlight important differences between two major guidelines, the 2016 Brain Trauma Foundation guidelines and the Lund Concept, along with recent preclinical and clinical data.

Recent Findings

While intracranial pressure (ICP) monitoring has been questioned, the majority of literature demonstrates benefit in severe TBI. The optimal cerebral perfusion pressure and ICP are yet unknown, but likely as important is the concept of ICP burden. The evidence for antihypertensive therapy is strengthening. Decompressive craniectomy improves mortality, but at the cost of increased morbidity. Plasma-based resuscitation has demonstrated benefit in multiple preclinical TBI studies.


The management of hemodynamics and intravascular volume are crucial in TBI. Based on recent evidence, ICP monitoring, antihypertensive therapy, minimal use of vasopressors/inotropes, and plasma resuscitation may improve outcomes.


Traumatic brain injury Secondary brain injury Intracranial pressure Intracranial hypertension Cerebral perfusion pressure Lund concept 


Author Contributions

Conception, design, drafting of manuscript: HWC and CSC. Critical revision of the manuscript for important intellectual content: HWC and CSC. Manuscript supervision: HWC and CSC.

Compliance with Ethics Guidelines

Conflict of interest

Henry W. Caplan declares no potential conflicts of interest. Charles S. Cox Jr holds equity and royalty interests in Cellvation Inc. as well as a sponsored research agreement and scientific advisory board position. Dr. Cox Jr has sponsored research and holds a scientific advisory board position for CBR, Inc. He also sponsored research for Hope Bio, Inc., as well as Sponsored research and received equity/royalty interest from Coagulex, Inc.

Human and Animal Rights and Informed Consent

All reported studies/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines).


Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Faul M, Xu L, Wald MM, Coronado V. Traumatic brain injury in the United States. Atlanta, GA: Centers for Disease Control and Prevention, National Center for Injury Prevention and Control. 2010.Google Scholar
  2. 2.
    Prevention CfDCa. Report to Congress on Traumatic Brain Injury in the United States: Epidemiology and Rehabilitation. United States: Epidemiology and Rehabilitation National Center for Injury Prevention and Control; Division of Unintentional Injury Prevention Atlanta, GA. 2015.Google Scholar
  3. 3.
    Simon DW, McGeachy MJ, Bayir H, Clark RS, Loane DJ, Kochanek PM. The far-reaching scope of neuroinflammation after traumatic brain injury. Nat Rev Neurol. 2017;13(3):171–91. Scholar
  4. 4.
    Unterberg AW, Stover J, Kress B, Kiening KL. Edema and brain trauma. Neuroscience. 2004;129(4):1021–9. Scholar
  5. 5.
    Kochanek PM, Dixon CE, Mondello S, Wang KKK, Lafrenaye A, Bramlett HM, et al. Multi-center pre-clinical consortia to enhance translation of therapies and biomarkers for traumatic brain injury: operation brain trauma therapy and beyond. Front Neurol. 2018;9:640. Scholar
  6. 6.
    Maas AIR, Menon DK, Adelson PD, Andelic N, Bell MJ, Belli A, et al. Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research. Lancet Neurol. 2017;16(12):987–1048. Scholar
  7. 7.
    Caplan HW, Cox CS, Bedi SS. Do microglia play a role in sex differences in TBI? J Neurosci Res. 2017;95(1–2):509–17. Scholar
  8. 8.
    Carney N, Totten AM, O’Reilly C, Ullman JS, Hawryluk GW, Bell MJ, et al. Guidelines for the management of severe traumatic brain injury. Fourth Ed Neurosurg. 2017;80(1):6–15. Scholar
  9. 9.
    •• Grande PO. Critical evaluation of the lund concept for treatment of severe traumatic head injury, 25 years after its introduction. Front Neurol. 2017;8:315. Written by the author of the original 1992 Lund Concept manuscipt, this review outlines the physiologic basis for the components of the LC, including critical pre-clinical and clinical studies. Furthermore, the author notes changes in both the LC and BTF guidelines over the last 25 years.
  10. 10.
    Bragge P, Synnot A, Maas AI, Menon DK, Cooper DJ, Rosenfeld JV, et al. A state-of-the-science overview of randomized controlled trials evaluating acute management of moderate-to-severe traumatic brain injury. J Neurotrauma. 2016;33(16):1461–78. Scholar
  11. 11.
    Nordstrom CH, Koskinen LO, Olivecrona M. Aspects on the physiological and biochemical foundations of neurocritical care. Front Neurol. 2017;8:274. Scholar
  12. 12.
    Rangel-Castilla L, Gasco J, Nauta HJ, Okonkwo DO, Robertson CS. Cerebral pressure autoregulation in traumatic brain injury. Neurosurg Focus. 2008;25(4):E7. Scholar
  13. 13.
    Chesnut RM, Temkin N, Carney N, Dikmen S, Rondina C, Videtta W, et al. A trial of intracranial-pressure monitoring in traumatic brain injury. N Engl J Med. 2012;367(26):2471–81. Scholar
  14. 14.
    Talving P, Karamanos E, Teixeira PG, Skiada D, Lam L, Belzberg H, et al. Intracranial pressure monitoring in severe head injury: compliance with Brain Trauma Foundation guidelines and effect on outcomes: a prospective study. J Neurosurg. 2013;119(5):1248–54. Scholar
  15. 15.
    Gerber LM, Chiu YL, Carney N, Hartl R, Ghajar J. Marked reduction in mortality in patients with severe traumatic brain injury. J Neurosurg. 2013;119(6):1583–90. Scholar
  16. 16.
    Farahvar A, Gerber LM, Chiu YL, Carney N, Hartl R, Ghajar J. Increased mortality in patients with severe traumatic brain injury treated without intracranial pressure monitoring. J Neurosurg. 2012;117(4):729–34. Scholar
  17. 17.
    • Guiza F, Depreitere B, Piper I, Citerio G, Chambers I, Jones PA et al. Visualizing the pressure and time burden of intracranial hypertension in adult and paediatric traumatic brain injury. Intensive Care Med. 2015;41(6):1067–76. This clinical trial effectively demonstrates the importance of the concept of ICP burden: that time spent over a critical ICP threshold leads to poor outcomes after TBI.
  18. 18.
    Koskinen LO, Olivecrona M, Grande PO. Severe traumatic brain injury management and clinical outcome using the Lund concept. Neuroscience. 2014;283:245–55. Scholar
  19. 19.
    Guiza F, Meyfroidt G, Piper I, Citerio G, Chambers I, Enblad P, et al. Cerebral perfusion pressure insults and associations with outcome in adult traumatic brain injury. J Neurotrauma. 2017;34(16):2425–31. Scholar
  20. 20.
    Hutchinson PJ, Jalloh I, Helmy A, Carpenter KL, Rostami E, Bellander BM, et al. Consensus statement from the 2014 International Microdialysis Forum. Intensive Care Med. 2015;41(9):1517–28. Scholar
  21. 21.
    Andresen M, Donnelly J, Aries M, Juhler M, Menon D, Hutchinson P, et al. Further controversies about brain tissue oxygenation pressure-reactivity after traumatic brain injury. Neurocrit Care. 2018;28(2):162–8. Scholar
  22. 22.
    Pigula FA, Wald SL, Shackford SR, Vane DW. The effect of hypotension and hypoxia on children with severe head injuries. J Pediatr Surg. 1993;28(3):310–4 discussion 5-6.CrossRefGoogle Scholar
  23. 23.
    Spaite DW, Hu C, Bobrow BJ, Chikani V, Barnhart B, Gaither JB, et al. Association of out-of-hospital hypotension depth and duration with traumatic brain injury mortality. Ann Emerg Med. 2017;70(4):522-30 e1. Scholar
  24. 24.
    Galvagno SM Jr, Fox EE, Appana SN, Baraniuk S, Bosarge PL, Bulger EM, et al. Outcomes after concomitant traumatic brain injury and hemorrhagic shock: a secondary analysis from the Pragmatic, Randomized Optimal Platelets and Plasma Ratios trial. J Trauma Acute Care Surg. 2017;83(4):668–74. Scholar
  25. 25.
    Bogert JN, Harvin JA, Cotton BA. Damage control resuscitation. J Intensive Care Med. 2016;31(3):177–86. Scholar
  26. 26.
    Krishnamoorthy V, Chaikittisilpa N, Kiatchai T, Vavilala M. Hypertension after severe traumatic brain injury: friend or foe? J Neurosurg Anesthesiol. 2017;29(4):382–7. Scholar
  27. 27.
    Hawkins WE, Clower BR. Myocardial damage after head trauma and simulated intracranial haemorrhage in mice: the role of the autonomic nervous system. Cardiovasc Res. 1971;5(4):524–9.CrossRefGoogle Scholar
  28. 28.
    Clifton GL, Ziegler MG, Grossman RG. Circulating catecholamines and sympathetic activity after head injury. Neurosurgery. 1981;8(1):10–4.CrossRefGoogle Scholar
  29. 29.
    Woolf PD, Hamill RW, Lee LA, Cox C, McDonald JV. The predictive value of catecholamines in assessing outcome in traumatic brain injury. J Neurosurg. 1987;66(6):875–82. Scholar
  30. 30.
    Rizoli SB, Jaja BN, Di Battista AP, Rhind SG, Neto AC, da Costa L, et al. Catecholamines as outcome markers in isolated traumatic brain injury: the COMA-TBI study. Crit Care. 2017;21(1):37. Scholar
  31. 31.
    Krishnamoorthy V, Mackensen GB, Gibbons EF, Vavilala MS. Cardiac dysfunction after neurologic injury: what do we know and where are we going? Chest. 2016;149(5):1325–31. Scholar
  32. 32.
    Meyfroidt G, Baguley IJ, Menon DK. Paroxysmal sympathetic hyperactivity: the storm after acute brain injury. Lancet Neurol. 2017;16(9):721–9. Scholar
  33. 33.
    Di Battista AP, Rhind SG, Hutchison MG, Hassan S, Shiu MY, Inaba K, et al. Inflammatory cytokine and chemokine profiles are associated with patient outcome and the hyperadrenergic state following acute brain injury. J Neuroinflamm. 2016;13:40. Scholar
  34. 34.
    Chaikittisilpa N, Krishnamoorthy V, Lele AV, Qiu Q, Vavilala MS. Characterizing the relationship between systemic inflammatory response syndrome and early cardiac dysfunction in traumatic brain injury. J Neurosci Res. 2018;96(4):661–70. Scholar
  35. 35.
    Krishnamoorthy V, Rowhani-Rahbar A, Chaikittisilpa N, Gibbons EF, Rivara FP, Temkin NR, et al. Association of early hemodynamic profile and the development of systolic dysfunction following traumatic brain injury. Neurocrit Care. 2017;26(3):379–87. Scholar
  36. 36.
    Asgeirsson B, Grande PO, Nordstrom CH. A new therapy of post-trauma brain oedema based on haemodynamic principles for brain volume regulation. Intensive Care Med. 1994;20(4):260–7.CrossRefGoogle Scholar
  37. 37.
    Grande PO. The “Lund Concept” for the treatment of severe head trauma–physiological principles and clinical application. Intensive Care Med. 2006;32(10):1475–84. Scholar
  38. 38.
    Zoerle T, Carbonara M, Zanier ER, Ortolano F, Bertani G, Magnoni S, et al. Rethinking neuroprotection in severe traumatic brain injury: toward bedside neuroprotection. Front Neurol. 2017;8:354. Scholar
  39. 39.
    Stocchetti N, Maas AI. Traumatic intracranial hypertension. N Engl J Med. 2014;370(22):2121–30. Scholar
  40. 40.
    Alali AS, Mukherjee K, McCredie VA, Golan E, Shah PS, Bardes JM, et al. Beta-blockers and traumatic brain injury: a systematic review, meta-analysis, and Eastern Association for the Surgery of Trauma Guideline. Ann Surg. 2017;266(6):952–61. Scholar
  41. 41.
    Ley EJ, Park R, Dagliyan G, Palestrant D, Miller CM, Conti PS, et al. In vivo effect of propranolol dose and timing on cerebral perfusion after traumatic brain injury. J Trauma. 2010;68(2):353–6. Scholar
  42. 42.
    Ley EJ, Clond MA, Bukur M, Park R, Chervonski M, Dagliyan G, et al. beta-adrenergic receptor inhibition affects cerebral glucose metabolism, motor performance, and inflammatory response after traumatic brain injury. J Trauma Acute Care Surg. 2012;73(1):33–40. Scholar
  43. 43.
    Liou DZ, Ko A, Volod O, Barmparas G, Harada MY, Martin MJ, et al. Thromboelastography after murine TBI and implications of beta-adrenergic receptor knockout. Neurocrit Care. 2016;25(1):145–52. Scholar
  44. 44.
    Wang J, Li J, Sheng X, Zhao H, Cao XD, Wang YQ, et al. Beta-adrenoceptor mediated surgery-induced production of pro-inflammatory cytokines in rat microglia cells. J Neuroimmunol. 2010;223(1–2):77–83. Scholar
  45. 45.
    Kota DJ, Prabhakara KS, van Brummen AJ, Bedi S, Xue H, DiCarlo B, et al. Propranolol and mesenchymal stromal cells combine to treat traumatic brain injury. Stem Cells Transl Med. 2016;5(1):33–44. Scholar
  46. 46.
    Genet GF, Bentzer P, Ostrowski SR, Johansson PI. Resuscitation with pooled and pathogen-reduced plasma attenuates the increase in brain water content following traumatic brain injury and hemorrhagic shock in rats. J Neurotrauma. 2017;34(5):1054–62. Scholar
  47. 47.
    Arbabi S, Campion EM, Hemmila MR, Barker M, Dimo M, Ahrns KS, et al. Beta-blocker use is associated with improved outcomes in adult trauma patients. J Trauma. 2007;62(1):56–61. discussion-2.CrossRefPubMedGoogle Scholar
  48. 48.
    Cotton BA, Snodgrass KB, Fleming SB, Carpenter RO, Kemp CD, Arbogast PG, et al. Beta-blocker exposure is associated with improved survival after severe traumatic brain injury. J Trauma. 2007;62(1):26–33. discussion-5.CrossRefPubMedGoogle Scholar
  49. 49.
    Inaba K, Teixeira PG, David JS, Chan LS, Salim A, Brown C, et al. Beta-blockers in isolated blunt head injury. J Am Coll Surg. 2008;206(3):432–8. Scholar
  50. 50.
    Zangbar B, Khalil M, Rhee P, Joseph B, Kulvatunyou N, Tang A, et al. Metoprolol improves survival in severe traumatic brain injury independent of heart rate control. J Surg Res. 2016;200(2):586–92. Scholar
  51. 51.
    Ko A, Harada MY, Barmparas G, Thomsen GM, Alban RF, Bloom MB, et al. Early propranolol after traumatic brain injury is associated with lower mortality. J Trauma Acute Care Surg. 2016;80(4):637–42. Scholar
  52. 52.
    Ahl R, Thelin EP, Sjolin G, Bellander BM, Riddez L, Talving P, et al. beta-Blocker after severe traumatic brain injury is associated with better long-term functional outcome: a matched case control study. Eur J Trauma Emerg Surg. 2017;43(6):783–9. Scholar
  53. 53.
    Murry JS, Hoang DM, Barmparas G, Harada MY, Bukur M, Bloom MB, et al. Prospective evaluation of early propranolol after traumatic brain injury. J Surg Res. 2016;200(1):221–6. Scholar
  54. 54.
    Bible LE, Pasupuleti LV, Alzate WD, Gore AV, Song KJ, Sifri ZC, et al. Early propranolol administration to severely injured patients can improve bone marrow dysfunction. J Trauma Acute Care Surg. 2014;77(1):54–60. discussion 59-60.CrossRefPubMedPubMedCentralGoogle Scholar
  55. 55.
    Aryan HE, Box KW, Ibrahim D, Desiraju U, Ames CP. Safety and efficacy of dexmedetomidine in neurosurgical patients. Brain Inj. 2006;20(8):791–8. Scholar
  56. 56.
    Schoeler M, Loetscher PD, Rossaint R, Fahlenkamp AV, Eberhardt G, Rex S, et al. Dexmedetomidine is neuroprotective in an in vitro model for traumatic brain injury. BMC Neurol. 2012;12:20. Scholar
  57. 57.
    Hoffman WE, Cheng MA, Thomas C, Baughman VL, Albrecht RF. Clonidine decreases plasma catecholamines and improves outcome from incomplete ischemia in the rat. Anesth Analg. 1991;73(4):460–4.CrossRefGoogle Scholar
  58. 58.
    Humble SS, Wilson LD, Leath TC, Marshall MD, Sun DZ, Pandharipande PP, et al. ICU sedation with dexmedetomidine after severe traumatic brain injury. Brain Inj. 2016;30(10):1266–70. Scholar
  59. 59.
    Ruiz-Ortega M, Lorenzo O, Suzuki Y, Ruperez M, Egido J. Proinflammatory actions of angiotensins. Curr Opin Nephrol Hypertens. 2001;10(3):321–9.CrossRefGoogle Scholar
  60. 60.
    Contant CF, Valadka AB, Gopinath SP, Hannay HJ, Robertson CS. Adult respiratory distress syndrome: a complication of induced hypertension after severe head injury. J Neurosurg. 2001;95(4):560–8. Scholar
  61. 61.
    Davison DL, Terek M, Chawla LS. Neurogenic pulmonary edema. Crit Care. 2012;16(2):212. Scholar
  62. 62.
    Cooper DJ, Rosenfeld JV, Murray L, Arabi YM, Davies AR, D’Urso P, et al. Decompressive craniectomy in diffuse traumatic brain injury. N Engl J Med. 2011;364(16):1493–502. Scholar
  63. 63.
    Hutchinson PJ, Kolias AG, Timofeev IS, Corteen EA, Czosnyka M, Timothy J, et al. Trial of decompressive craniectomy for traumatic intracranial hypertension. N Engl J Med. 2016;375(12):1119–30. Scholar
  64. 64.
    Zhang D, Xue Q, Chen J, Dong Y, Hou L, Jiang Y, et al. Decompressive craniectomy in the management of intracranial hypertension after traumatic brain injury: a systematic review and meta-analysis. Sci Rep. 2017;7(1):8800. Scholar
  65. 65.
    Olivecrona M, Rodling-Wahlstrom M, Naredi S, Koskinen LO. Effective ICP reduction by decompressive craniectomy in patients with severe traumatic brain injury treated by an ICP-targeted therapy. J Neurotrauma. 2007;24(6):927–35. Scholar
  66. 66.
    Wilson MH. Monro-Kellie 2.0: the dynamic vascular and venous pathophysiological components of intracranial pressure. J Cereb Blood Flow Metab. 2016;36(8):1338–50. Scholar
  67. 67.
    Scalea TM, Bochicchio GV, Habashi N, McCunn M, Shih D, McQuillan K, et al. Increased intra-abdominal, intrathoracic, and intracranial pressure after severe brain injury: multiple compartment syndrome. J Trauma. 2007;62(3):647–56. discussion 56.CrossRefPubMedGoogle Scholar
  68. 68.
    Joseph DAK, Dutton RP, Aarabi B, Scalea TM. Decompressive laparotomy to treat intractable intracranial hypertension after traumatic brain injury. J Trauma: Injury Infect Crit Care. 2004;57(4):687–95. Scholar
  69. 69.
    Asehnoune K, Roquilly A, Cinotti R. Respiratory management in patients with severe brain injury. Crit Care. 2018;22(1):76. Scholar
  70. 70.
    Boone MD, Jinadasa SP, Mueller A, Shaefi S, Kasper EM, Hanafy KA, et al. The effect of positive end-expiratory pressure on intracranial pressure and cerebral hemodynamics. Neurocrit Care. 2017;26(2):174–81. Scholar
  71. 71.
    Nemer SN, Caldeira JB, Santos RG, Guimaraes BL, Garcia JM, Prado D, et al. Effects of positive end-expiratory pressure on brain tissue oxygen pressure of severe traumatic brain injury patients with acute respiratory distress syndrome: a pilot study. J Crit Care. 2015;30(6):1263–6. Scholar
  72. 72.
    Sharma D, Vavilala MS. Lund concept for the management of traumatic brain injury: a physiological principle awaiting stronger evidence. J Neurosurg Anesthesiol. 2011;23(4):363–7. Scholar
  73. 73.
    Holcomb JB, Pati S. Optimal trauma resuscitation with plasma as the primary resuscitative fluid: the surgeon’s perspective. Hematol Am Soc Hematol Educ Progr. 2013;2013:656–9. Scholar
  74. 74.
    Holcomb JB, Tilley BC, Baraniuk S, Fox EE, Wade CE, Podbielski JM, et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA. 2015;313(5):471–82. Scholar
  75. 75.
    Finfer S, Norton R, Bellomo R, Boyce N, French J, Myburgh J. The SAFE study: saline vs albumin for fluid resuscitation in the critically ill. Vox Sang. 2004;87(Suppl 2):123–31. Scholar
  76. 76.
    Cooper DJ, Myburgh J, Heritier S, Finfer S, Bellomo R, Billot L, et al. Albumin resuscitation for traumatic brain injury: is intracranial hypertension the cause of increased mortality? J Neurotrauma. 2013;30(7):512–8. Scholar
  77. 77.
    The Brain Trauma Foundation. The American Association of Neurological Surgeons. The Joint Section on Neurotrauma and Critical Care. Guidelines for cerebral perfusion pressure. J Neurotrauma. 2000;17(6-7):507–11. Scholar
  78. 78.
    Ertmer C, Van Aken H. Fluid therapy in patients with brain injury: what does physiology tell us? Crit Care. 2014;18(2):119. Scholar
  79. 79.
    Semler MW, Self WH, Wanderer JP, Ehrenfeld JM, Wang L, Byrne DW, et al. Balanced crystalloids versus saline in critically Ill adults. N Engl J Med. 2018;378(9):829–39. Scholar
  80. 80.
    Ko A, Harada MY, Barmparas G, Smith EJT, Birch K, Barnard ZR, et al. Limit crystalloid resuscitation after traumatic brain injury. Am Surg. 2017;83(12):1447–52.PubMedGoogle Scholar
  81. 81.
    Tyagi R, Donaldson K, Loftus CM, Jallo J. Hypertonic saline: a clinical review. Neurosurg Rev. 2007;30(4):277–89. discussion 89-90.CrossRefPubMedGoogle Scholar
  82. 82.
    Mangat HS. Hypertonic saline infusion for treating intracranial hypertension after severe traumatic brain injury. Crit Care. 2018;22(1):37. Scholar
  83. 83.
    Oddo M, Poole D, Helbok R, Meyfroidt G, Stocchetti N, Bouzat P, et al. Fluid therapy in neurointensive care patients: ESICM consensus and clinical practice recommendations. Intensive Care Med. 2018;44(4):449–63. Scholar
  84. 84.
    Berger-Pelleiter E, Emond M, Lauzier F, Shields JF, Turgeon AF. Hypertonic saline in severe traumatic brain injury: a systematic review and meta-analysis of randomized controlled trials. CJEM. 2016;18(2):112–20. Scholar
  85. 85.
    Alnemari AM, Krafcik BM, Mansour TR, Gaudin D. A comparison of pharmacologic therapeutic agents used for the reduction of intracranial pressure after traumatic brain injury. World Neurosurg. 2017;106:509–28. Scholar
  86. 86.
    Burgess S, Abu-Laban RB, Slavik RS, Vu EN, Zed PJ. A systematic review of randomized controlled trials comparing hypertonic sodium solutions and mannitol for traumatic brain injury: implications for emergency department management. Ann Pharmacother. 2016;50(4):291–300. Scholar
  87. 87.
    Oernbo EK, Lykke K, Steffensen AB, Tollner K, Kruuse C, Rath MF, et al. Cerebral influx of Na(+) and Cl(−) as the osmotherapy-mediated rebound response in rats. Fluids Barriers CNS. 2018;15(1):27. Scholar
  88. 88.
    Roquilly A, Lasocki S, Moyer JD, Huet O, Perrigault PF, Dahyot-Fizelier C, et al. COBI (COntinuous hyperosmolar therapy for traumatic Brain-Injured patients) trial protocol: a multicentre randomised open-label trial with blinded adjudication of primary outcome. BMJ Open. 2017;7(9):e018035. Scholar
  89. 89.
    Vedantam A, Robertson CS, Gopinath SP. Morbidity and mortality associated with hypernatremia in patients with severe traumatic brain injury. Neurosurg Focus. 2017;43(5):E2. Scholar
  90. 90.
    Kumasaka K, Marks JA, Eisenstadt R, Murcy MA, Samadi D, Li S, et al. In vivo leukocyte-mediated brain microcirculatory inflammation: a comparison of osmotherapies and progesterone in severe traumatic brain injury. Am J Surg. 2014;208(6):961–8. discussion 7-8.CrossRefPubMedPubMedCentralGoogle Scholar
  91. 91.
    Schreibman DL, Hong CM, Keledjian K, Ivanova S, Tsymbalyuk S, Gerzanich V, et al. Mannitol and hypertonic saline reduce swelling and modulate inflammatory markers in a rat model of intracerebral hemorrhage. Neurocrit Care. 2018;29(2):253–63. Scholar
  92. 92.
    Huang LQ, Zhu GF, Deng YY, Jiang WQ, Fang M, Chen CB, et al. Hypertonic saline alleviates cerebral edema by inhibiting microglia-derived TNF-alpha and IL-1beta-induced Na-K-Cl Cotransporter up-regulation. J Neuroinflamm. 2014;11:102. Scholar
  93. 93.
    Zeng WX, Han YL, Zhu GF, Huang LQ, Deng YY, Wang QS, et al. Hypertonic saline attenuates expression of Notch signaling and proinflammatory mediators in activated microglia in experimentally induced cerebral ischemia and hypoxic BV-2 microglia. BMC Neurosci. 2017;18(1):32. Scholar
  94. 94.
    Wen M, Ye J, Han Y, Huang L, Yang H, Jiang W, et al. Hypertonic saline regulates microglial M2 polarization via miR-200b/KLF4 in cerebral edema treatment. Biochem Biophys Res Commun. 2018;499(2):345–53. Scholar
  95. 95.
    McIntyre LA, Fergusson DA, Hutchison JS, Pagliarello G, Marshall JC, Yetisir E, et al. Effect of a liberal versus restrictive transfusion strategy on mortality in patients with moderate to severe head injury. Neurocrit Care. 2006;5(1):4–9.CrossRefGoogle Scholar
  96. 96.
    Yamal JM, Rubin ML, Benoit JS, Tilley BC, Gopinath S, Hannay HJ, et al. Effect of hemoglobin transfusion threshold on cerebral hemodynamics and oxygenation. J Neurotrauma. 2015;32(16):1239–45. Scholar
  97. 97.
    Carr KR, Rodriguez M, Ottesen A, Michalek J, Son C, Patel V, et al. Association between relative anemia and early functional recovery after severe traumatic brain injury (TBI). Neurocrit Care. 2016;25(2):185–92. Scholar
  98. 98.
    Robertson CS, Hannay HJ, Yamal JM, Gopinath S, Goodman JC, Tilley BC, et al. Effect of erythropoietin and transfusion threshold on neurological recovery after traumatic brain injury: a randomized clinical trial. JAMA. 2014;312(1):36–47. Scholar
  99. 99.
    Cardenas JC, Cap AP, Swartz MD, Huby Mdel P, Baer LA, Matijevic N, et al. Plasma resuscitation promotes coagulation homeostasis following shock-induced hypercoagulability. Shock. 2016;45(2):166–73. Scholar
  100. 100.
    Albert V, Subramanian A, Agrawal D, Pati HP, Gupta SD, Mukhopadhyay AK. Acute traumatic endotheliopathy in isolated severe brain injury and its impact on clinical outcome. Med Sci. 2018;6(1):2. Scholar
  101. 101.
    Folkerson LE, Sloan D, Davis E, Kitagawa RS, Cotton BA, Holcomb JB, et al. Coagulopathy as a predictor of mortality after penetrating traumatic brain injury. Am J Emerg Med. 2018;36(1):38–42. Scholar
  102. 102.
    • Jin G, DeMoya MA, Duggan M, Knightly T, Mejaddam AY, Hwabejire J et al. Traumatic brain injury and hemorrhagic shock: evaluation of different resuscitation strategies in a large animal model of combined insults. Shock. 2012;38(1):49–56. This pre-clinical study, as well as other from the same group below, demonstrates the potential for plasma-based resuscitation to reduce hemorrhage progression and improve outcomes after TBI.
  103. 103.
    Halaweish I, Bambakidis T, He W, Linzel D, Chang Z, Srinivasan A, et al. Early resuscitation with fresh frozen plasma for traumatic brain injury combined with hemorrhagic shock improves neurologic recovery. J Am Coll Surg. 2015;220(5):809–19. Scholar
  104. 104.
    Hwabejire JO, Imam AM, Jin G, Liu B, Li Y, Sillesen M, et al. Differential effects of fresh frozen plasma and normal saline on secondary brain damage in a large animal model of polytrauma, hemorrhage and traumatic brain injury. J Trauma Acute Care Surg. 2013;75(6):968–74. discussion 74-5.CrossRefPubMedGoogle Scholar
  105. 105.
    Halaweish I, Bambakidis T, Nikolian VC, Georgoff P, Bruhn P, Piascik P, et al. Early resuscitation with lyophilized plasma provides equal neuroprotection compared with fresh frozen plasma in a large animal survival model of traumatic brain injury and hemorrhagic shock. J Trauma Acute Care Surg. 2016;81(6):1080–7. Scholar
  106. 106.
    Georgoff PE, Nikolian VC, Halaweish I, Chtraklin K, Bruhn PJ, Eidy H, et al. Resuscitation with lyophilized plasma is safe and improves neurological recovery in a long-term survival model of swine subjected to traumatic brain injury, hemorrhagic shock, and polytrauma. J Neurotrauma. 2017;34(13):2167–75. Scholar
  107. 107.
    Chang R, Folkerson LE, Sloan D, Tomasek JS, Kitagawa RS, Choi HA, et al. Early plasma transfusion is associated with improved survival after isolated traumatic brain injury in patients with multifocal intracranial hemorrhage. Surgery. 2017;161(2):538–45. Scholar
  108. 108.
    Patel MB, McKenna JW, Alvarez JM, Sugiura A, Jenkins JM, Guillamondegui OD, et al. Decreasing adrenergic or sympathetic hyperactivity after severe traumatic brain injury using propranolol and clonidine (DASH After TBI Study): study protocol for a randomized controlled trial. Trials. 2012;13:177. Scholar
  109. 109.
    Bedi SS, Hetz R, Thomas C, Smith P, Olsen AB, Williams S, et al. Intravenous multipotent adult progenitor cell therapy attenuates activated microglial/macrophage response and improves spatial learning after traumatic brain injury. Stem Cells Transl Med. 2013;2(12):953–60. Scholar
  110. 110.
    Bedi SS, Aertker BM, Liao GP, Caplan HW, Bhattarai D, Mandy F, et al. Therapeutic time window of multipotent adult progenitor therapy after traumatic brain injury. J Neuroinflamm. 2018;15(1):84. Scholar
  111. 111.
    Cox CS Jr, Baumgartner JE, Harting MT, Worth LL, Walker PA, Shah SK, et al. Autologous bone marrow mononuclear cell therapy for severe traumatic brain injury in children. Neurosurgery. 2011;68(3):588–600. Scholar
  112. 112.
    Jackson ML, Srivastava AK, Cox CS Jr. Preclinical progenitor cell therapy in traumatic brain injury: a meta-analysis. J Surg Res. 2017;214:38–48. Scholar
  113. 113.
    Liao GP, Harting MT, Hetz RA, Walker PA, Shah SK, Corkins CJ, et al. Autologous bone marrow mononuclear cells reduce therapeutic intensity for severe traumatic brain injury in children. Pediatr Crit Care Med. 2015;16(3):245–55. Scholar
  114. 114.
    Cox CS Jr, Hetz RA, Liao GP, Aertker BM, Ewing-Cobbs L, Juranek J, et al. Treatment of severe adult traumatic brain injury using bone marrow mononuclear cells. Stem Cells. 2017;35(4):1065–79. Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Pediatric SurgeryMcGovern Medical School at the University of Texas Health Science Center at HoustonHoustonUSA

Personalised recommendations